VALENCIA NUTRITION LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 28.45 INR | -1.08% |
|
-10.70% | -52.58% |
| 06/03 | Valencia Nutrition to Raise Up to INR217.8 Million Via Rights Issue | MT |
| 2023 | Valencia Nutrition Limited Reports Earnings Results for the Half Year Ended September 30, 2023 | CI |
Valuation
| Fiscal Period: March | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| Capitalization 1 | 256.9 | 106.1 | 82.66 | 122.3 |
| Enterprise Value (EV) 1 | 233.5 | 109.3 | 88.19 | 143.4 |
| P/E ratio | -4.85 x | -2.97 x | -12.5 x | -9.69 x |
| Yield | - | - | - | - |
| Capitalization / Revenue | 10.8 x | 11.1 x | - | 8.37 x |
| EV / Revenue | 9.84 x | 11.4 x | - | 9.82 x |
| EV / EBITDA | -5.6 x | -3.82 x | -15.7 x | -12.1 x |
| EV / FCF | -5.11 x | -6.49 x | -8.01 x | -13.4 x |
| FCF Yield | -19.6% | -15.4% | -12.5% | -7.45% |
| Price to Book | 5.31 x | 8.43 x | 13.9 x | -18.4 x |
| Nbr of stocks (in thousands) | 5,585 | 5,585 | 5,585 | 5,585 |
| Reference price 2 | 46.00 | 19.00 | 14.80 | 21.90 |
| Announcement Date | 07/09/20 | 03/09/21 | 06/09/22 | 06/09/23 |
1INR in Million2INR
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: March | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net sales 1 | 4.255 | 14.95 | 23.73 | 9.548 | - | 14.61 |
| EBITDA 1 | -10.83 | -20.77 | -41.73 | -28.64 | -5.63 | -11.89 |
| EBIT 1 | -11.39 | -21.41 | -42.96 | -29.98 | -6.385 | -12.63 |
| Operating Margin | -267.73% | -143.27% | -181.07% | -314.02% | - | -86.46% |
| Earnings before Tax (EBT) 1 | -11.6 | -21.41 | -43.37 | -35.76 | -6.617 | -12.63 |
| Net income 1 | -11.6 | -21.41 | -43.37 | -35.76 | -6.617 | -12.63 |
| Net margin | -272.55% | -143.27% | -182.78% | -374.58% | - | -86.46% |
| EPS 2 | -4.362 | -6.047 | -9.476 | -6.403 | -1.185 | -2.261 |
| Free Cash Flow 1 | -9.386 | -16.98 | -45.74 | -16.84 | -11.01 | -10.68 |
| FCF margin | -220.6% | -113.61% | -192.77% | -176.4% | - | -73.12% |
| FCF Conversion (EBITDA) | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - |
| Announcement Date | 19/12/19 | 19/12/19 | 07/09/20 | 03/09/21 | 06/09/22 | 06/09/23 |
1INR in Million2INR
Estimates
Balance Sheet Analysis
| Fiscal Period: Maart | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | 3.15 | 5.52 | 21.1 |
| Net Cash position 1 | 9.66 | 0.77 | 23.4 | - | - | - |
| Leverage (Debt/EBITDA) | - | - | - | -0.1101 x | -0.9812 x | -1.77 x |
| Free Cash Flow 1 | -9.39 | -17 | -45.7 | -16.8 | -11 | -10.7 |
| ROE (net income / shareholders' equity) | -2,615% | -242% | -158% | -117% | -71.3% | 3,639% |
| ROA (Net income/ Total Assets) | -73.3% | -88.5% | -65.3% | -35.7% | -13% | -30.2% |
| Assets 1 | 15.81 | 24.21 | 66.44 | 100.2 | 50.85 | 41.85 |
| Book Value Per Share 2 | 3.450 | 1.710 | 8.660 | 2.250 | 1.070 | -1.190 |
| Cash Flow per Share 2 | 3.550 | 0.6800 | 5.350 | 0.4200 | 0.0800 | 0.1400 |
| Capex 1 | 0.59 | 0.85 | 20.5 | 1.16 | - | - |
| Capex / Sales | 13.96% | 5.68% | 86.56% | 12.18% | - | - |
| Announcement Date | 19/12/19 | 19/12/19 | 07/09/20 | 03/09/21 | 06/09/22 | 06/09/23 |
1INR in Million2INR
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| -52.58% | 4.76M | |
| -.--% | 843M | |
| -.--% | 671M | |
| +34.88% | 492M | |
| +19.13% | 231M | |
| -.--% | 151M | |
| +113.04% | 59.29M |
- Stock Market
- Equities
- VALENCIA Stock
- Financials Valencia Nutrition Limited
